26 results on '"Ueno, Saori"'
Search Results
2. Moving scope technique improves technical success rate of device insertion during EUS-guided hepaticogastrostomy (with video).
- Author
-
Bessho, Kimi, Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Sakamoto, Jun, Yamamoto, Yoshitaro, Uba, Yuki, Tomita, Mitsuki, Hattori, Nobuhiro, Nakamura, Junichi, and Nishikawa, Hiroki
- Subjects
INTRAHEPATIC bile ducts ,BILIARY tract ,ENDOSCOPIC ultrasonography ,RANDOMIZED controlled trials ,RECEIVER operating characteristic curves ,CHOLANGIOGRAPHY - Abstract
Background: Technical tips for device insertion during endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) have not been reported. To improve the technical success rate of device insertion without unnecessary tract dilation, the pushing force should be transmitted directly from the channel of the echoendoscope to the intrahepatic bile duct. Objectives: We developed a novel technique, termed the 'moving scope technique', the feasibility of which during EUS-HGS is described. Design: Retrospective study. Methods: The primary outcome of this study was the technical success rate of dilation device insertion without electrocautery dilation after the moving scope technique. The initial technical success rate of dilation device insertion was defined as successful insertion into the biliary tract. If dilation device insertion failed, the moving scope technique was attempted. Results: A total of 143 patients were enrolled in this study. The initial technical success rate for device insertion was 80.4% (115/143). The moving scope technique was therefore attempted in 28 patients. The mean angle between the intrahepatic bile duct and the guidewire was improved to 141.0° and resulted in a technical success rate of 100% (28/28). The area under the ROC curve (AUC) was 0.88, and 120° predicted successful dilation device insertion with sensitivity of 88.0% and specificity of 78.8%. Bile peritonitis (n = 8) and cholangitis (n = 2) were observed as adverse events, but were not severe. Conclusion: In conclusion, the moving scope technique may be helpful during EUS-HGS to achieve successful insertion of the dilation device into the biliary tract. These results should be evaluated in a prospective randomized controlled trial. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Liver impaction technique improves technical success rate of guidewire insertion during EUS-guided hepaticogastrostomy (with video).
- Author
-
Nakamura, Junichi, Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Uba, Yuki, Tomita, Mitsuki, Bessho, Kimi, Hattori, Nobuhiro, and Nishikawa, Hiroki
- Subjects
BILIARY tract ,BILE ducts ,LIVER ,ENDOSCOPIC ultrasonography ,CHOLANGITIS ,CHOLANGIOGRAPHY - Abstract
Background: If the guidewire becomes kinked by the needle, guidewire manipulation may be difficult, and can cause complications such as guidewire shearing or injury during endoscopic ultrasound (EUS)-guided hepaticogastrostomy (HGS). To overcome this matter, we have previously described a technical tip for preventing guidewire injury, termed 'liver impaction technique'. However, its technical feasibility has been not reported in the setting of a large patient cohort. Objectives: The aim of study was to evaluate the clinical usefulness of the liver impaction technique during EUS-HGS. Design: Retrospective, single-center study. Methods: This retrospective study included consecutive patients who underwent EUS-HGS between April 2018 and September 2022. The primary outcome of this study was the technical success rate of guidewire insertion using the liver impaction technique. Results: A total of 166 patients were enrolled in this study. Initial successful guidewire insertion without using liver impaction technique was obtained in 108 patients (65.1%). Among 58 patients in whom guidewire insertion failed initially, guidewire advancement into the periphery of the bile duct was observed in 32 patients (55.2%) and into a non-interest bile duct branch was observed in 26 patients (44.8%). Liver impaction technique contributed to increasing the technical success rate of guidewire insertion from 65.1% to 95.8%. Overall, adverse events were observed in 12 patients (7.2%; bile peritonitis n = 9, cholangitis n = 3), and these adverse events were Grade I. Among patients who underwent liver impaction technique (n = 58), adverse events were observed in two patients (3.4%; bile peritonitis). Also, guidewire sharing was not observed in any patients during liver impaction technique. Conclusions: In conclusion, the liver impaction technique may be helpful during EUS-HGS to obtain successful guidewire insertion into the biliary tract of interest. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Prospective registration study of diagnostic yield and sample size in forceps biopsy using a novel device under digital cholangioscopy guidance with macroscopic on‐site evaluation.
- Author
-
Ogura, Takeshi, Hirose, Yoshinobu, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Miyano, Akira, Yamamoto, Yoshitaro, Ueshima, Kazuya, and Higuchi, Kazuhide
- Abstract
Background: Although the SpyGlass Direct Visualization System can be clinically useful for diagnosing indeterminate biliary stricture, it employs SpyBite forceps, which typically obtain only a small amount of tissue and have a low sampling rate. An improved forceps biopsy device for SpyGlass DS has recently been released (SpyBite MAX). The aim of this prospective registration study was to assess the diagnostic yield and efficacy of histological biopsy tissue obtained with SpyBite MAX forceps compared with SpyBite forceps in patients with indeterminate biliary stricture. Methods: The primary outcome of the study was the diagnostic accuracy of biopsy specimens obtained by SpyBite MAX forceps. The secondary outcomes were tissue size, number of forceps biopsies, rate of obtaining adequate tissue, and adverse events in the SpyBite MAX forceps group compared with the SpyBite group. Results: Forceps biopsies using SpyBite MAX (n = 47) and SpyBite (n = 50) were performed successfully in all patients. The number of biopsies performed before visible core tissue was obtained was significantly lower in the SpyBite (mean, 1.5 ± 0.7) than in the SpyBite forceps group (mean, 2.3 ± 1.1 mm; P <.001). Tissue sample size was larger in the SpyBite MAX group (mean, 1.8 ± 1.6 mm2) than in the SpyBite group (mean, 1.0 ± 0.9 mm2; P =.004) but there was no significant difference in diagnostic accuracy. Conclusion: Improvements in dedicated forceps for biopsy in SpyGlass DS may contribute to improving the rates of adequate tissue and tissue sample size obtained, and to reducing the number of forceps biopsies required. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Gastrojejunostomy versus endoscopic duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer: a propensity score-matched analysis.
- Author
-
Tamura, Takashi, Mamoru, Takenaka, Terai, Taichi, Ogura, Takeshi, Tani, Masaji, Shimokawa, Toshio, Kitahata, Yuji, Matsumoto, Ippei, Mitoro, Akira, Asakuma, Mitsuhiro, Inatomi, Osamu, Omoto, Shunsuke, Sho, Masayuki, Ueno, Saori, Maehira, Hiromitsu, and Kitano, Masayuki
- Subjects
GASTRIC outlet obstruction ,SURGICAL stents ,PANCREATIC cancer ,GASTRIC bypass ,DUODENAL obstructions ,OBSTRUCTIVE jaundice - Abstract
Background: Treatments for patients with gastric outlet obstruction (GOO) due to unresectable pancreatic cancers (URPC) include gastrojejunostomy (GJJ) and endoscopic duodenal stent placement (EDSP). This study compared the efficacy and safety of GJJ and EDSP in patients with GOO due to URPC. Methods: This study retrospectively evaluated consecutive patients with GOO due to URPC who underwent GJJ or EDSP between April 2016 and March 2020. The efficacy and safety of GJJ and EDSP were compared with propensity score analysis. Subgroup analyses of overall survival (OS) were compared after propensity matching. Results: Data were obtained from 54 patients who underwent GJJ and from 73 who underwent EDSP at five tertiary care hospitals. After propensity matching, OS was significantly longer in patients who underwent GJJ than EDSP (110 vs. 63 days, respectively; p = 0.019). Evaluation of long-term adverse events showed that the frequency of cholangitis and obstructive jaundice was significantly lower in the matched GJJ than in the matched EDSP group (p = 0.012). Subgroup analyses showed that OS in patients with good performance status (PS; p = 0.041), biliary obstruction (p = 0.007), and duodenal obstruction near the papilla (p = 0.027), and those receiving chemotherapy (p = 0.010), was significantly longer in the matched GJJ group than in matched EDSP group. Conclusion: GJJ provides longer OS than EDSP for patients with GOO caused by URPC, especially for patients with good PS, biliary obstruction, and duodenal obstruction near the papilla, and those receiving chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Can Lemborexant for Insomnia Prevent Delirium in High-Risk Patients with Pancreato-Biliary Disease after Endoscopic Procedures under Deep Sedation?
- Author
-
Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Miyano, Akira, Yamamoto, Yoshitaro, Bessho, Kimi, Tomita, Mitsuki, Hattori, Nobuhiro, Nakamura, Junichi, and Nishikawa, Hiroki
- Subjects
DELIRIUM ,INSOMNIA ,ALCOHOL drinking ,CHOLANGITIS ,INSOMNIACS - Abstract
Background and aim: Pancreato-biliary patients who undergo endoscopic procedures have high potential risk of delirium. Although benzodiazepine has traditionally been used to treat insomnia, this drug might increase delirium. Lemborexant may be useful for patients with insomnia, without worsening delirium, although there is no evidence for high-risk patients with pancreato-biliary disease. The aim of this pilot study was to evaluate the safety and efficacy of lemborexant for insomnia and the frequency of delirium after endoscopic procedures under deep sedation in patients with pancreato-biliary disease. Method: This retrospective study included consecutive patients who were administered lemborexant after endoscopic procedures for pancreato-biliary disease between September 2020 and June 2022. The primary outcome of this study was evaluation of the safety and efficacy of lemborexant for insomnia. Frequency of delirium was the secondary outcome. Result: In total, 64 patients who had the complication of insomnia after an endoscopic procedure were included in the study. Risk factors for delirium were advanced age (n = 36, 56.3%), dementia (n = 10, 15.6%), and regular alcohol use (n = 13, 20.3%), as well as the sedatives midazolam and pentazocine that were administered to all patients at the time of the endoscopic procedure. Successful asleep was achieved by 61/64 patients (95.3%). No fall event was observed during the night following the procedure in any patient. However, mild consciousness transformation was observed in one patient. Conclusions: In conclusion, lemborexant use may be effective and safe for use after endoscopic procedures in pancreato-biliary patients, without increasing the risk of delirium. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Comparison of Endoscopic Hemostasis for Endoscopic Sphincterotomy Bleeding between a Novel Self-Assembling Peptide and Conventional Technique.
- Author
-
Uba, Yuki, Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Miyano, Akira, Yamamoto, Yoshitaro, Bessho, Kimi, Tomita, Mitsuki, Nakamura, Junichi, Hakoda, Akitoshi, and Nishikawa, Hiroki
- Subjects
ENDOSCOPIC hemostasis ,PEPTIDES ,HEMORRHAGE ,HEMOSTASIS - Abstract
Introduction: Recently, a novel self-assembling peptide hemostatic gel has become available in Japan. However, the safety and efficacy of this novel self-assembling peptide hemostatic gel remain unclear for bleeding after EST. The aim of this study was to evaluate the safety and efficacy of a novel self-assembling peptide hemostatic gel for bleeding after EST, and to perform a comparison to a conventional endoscopic hemostasis technique. Method: This retrospective study was carried out between January 2019 and October 2022. Patients who developed bleeding associated with EST were enrolled. The patients were divided into two groups based on the hemostasis technique used: a conventional hemostasis technique (Group A) or a novel self-assembling peptide hemostatic gel hemostasis technique (Group B). Result: A total of 62 patients (Group A, n = 36; Group B, n = 26) were included. Endoscopic hemostasis was initially obtained in 72.2% (26/32) of patients in Group A and in 88.4% (23/26) of patients in Group B, which was not significantly different (p = 0.1320). However, the procedure time was significantly shorter in Group B (mean, 9.38 min) compared with Group A (mean, 15.4 min) (p = 0.0103). There were no significant differences in the severity of bleeding between the two groups (p = 0.4530). Post-EST bleeding was observed in six patients (Group A, n = 4; Group B, n = 2). Adverse events were more frequently observed in Group A (n = 12) than in Group B (n = 1) (p = 0.0457). Conclusions: PuraStat application for EST bleeding might be safe and effective, and is comparable to the conventional endoscopic hemostasis technique, although further prospective randomized trials are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Prospective multicenter evaluation of moving cell metallic stents in endoscopic multiple stent deployment for hepatic hilar obstruction.
- Author
-
Kawai, Junichi, Ogura, Takeshi, Takenaka, Mamoru, Shiomi, Hideyuki, Ueshima, Kazuya, Ueno, Saori, Okuda, Atsushi, Matsuno, Jun, Minaga, Kousuke, Omoto, Shunsuke, Nakai, Atsushi, Ikegawa, Takuya, Hakoda, Akitoshi, and Higuchi, Kazuhide
- Abstract
Background and Aim: Bilateral stent deployment for malignant biliary obstruction (MHBO) can be achieved using side‐by‐side (SBS) or stent‐in‐stent (SIS) procedures. Compared with SBS techniques, the procedural steps of SIS are technically complex due to the necessity of introducing the delivery system into a contralateral biliary tract through the mesh of the SEMS. To overcome this issue, a novel uncovered SEMS, the HILZO Moving Cell Stent (MCS) has been released. The present study examined the technical feasibility of treating MHBO using bilateral deployment of this novel stent without dilating the mesh of the first stent to achieve insertion of the second stent within a single session, using a prospective, multicenter setting. Method: The primary outcome in the present study was the technical success rate. Technical success was defined as deployment of bilateral MCSs into two or more biliary tracts using SIS without a dilation device in a single‐session. Results: A total of 27 patients with complications of MHBO were enrolled in this study. Bilateral SIS using two MCS was successfully performed in 23 patients without using dilation devices among 27 patients (initial technical success rate; 85.2%). Median time to recurrent biliary obstruction (TRBO) was 271 days. Stent dysfunction was observed in 12 patients (44.4%), and re‐intervention was successfully performed in all patients without one patient who instead received best supportive care. Conclusions: The SIS technique using MCS without dilation of the mesh may be technically feasible and safe. In addition, this may be useful for re‐intervention. Further comparative randomized trials are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Endoscopic bilateral revision after metal stent deployment for hepatic hilar obstruction using molting technique (with videos).
- Author
-
Yamamura, Masahiro, Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Yamada, Masanori, Ueshima, Kazuya, Matsuno, Jun, Yamamoto, Yoshitaro, and Higuchi, Kazuhide
- Subjects
CHOLANGIOGRAPHY ,ENDOSCOPIC retrograde cholangiopancreatography ,ENDOSCOPIC ultrasonography ,MOLTING ,BILE ducts - Abstract
Background: After multiple uncovered self-expandable metal stent (UCSEMS) deployments, endoscopic revision becomes complex and potentially challenging. A novel stent delivery system with a dilation function has recently been developed in Japan. This study evaluated the technical feasibility of this device for patients with unresectable malignant hilar biliary obstruction (MHO) after multiple UCSEMS deployments. Method: Participants comprised consecutive patients with unresectable MHO who had undergone multiple UCSEMS deployments and required endoscopic revision for the right or left hepatic bile ducts, as decided by cholangiography under endoscopic retrograde cholangiopancreatography (ERCP) guidance. Results: A total of 14 patients requiring endoscopic revision of right and left hepatic bile ducts were enrolled in this study. Among these 14 patients, guidewire insertion through the mesh of previously placed stents failed in 2 patients. As a result, these two patients underwent only unilateral UCSEMS deployment. Because clinical success was not obtained, transmural placement of the UCSEMS under Endoscopic Ultrasound (EUS) guidance to the segment of the liver not being drained was performed in those patients. The molting technique was attempted in 12 patients, proving successful in all patients. The technical success rate was therefore 92.8% (12/14). Mean procedure time was 23.2 min. Conclusion: This novel stent delivery system with a dilation function may be useful in endoscopic revision techniques for bilateral UCSEMS deployment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Expanding indications for endoscopic ultrasound‐guided hepaticogastrostomy for patients with insufficient dilatation of the intrahepatic bile duct using a 22G needle combined with a novel 0.018‐inch guidewire (with video).
- Author
-
Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, Yamada, Masanori, Ueshima, Kazuya, Matsuno, Jun, Yamamoto, Yoshitaro, and Higuchi, Kazuhide
- Subjects
INTRAHEPATIC bile ducts ,ENDOSCOPIC ultrasonography ,BILE ducts ,NEEDLES & pins - Abstract
A prerequisite for endoscopic ultrasound (EUS)‐guided hepaticogastrostomy (HGS) is adequate dilation of the intrahepatic bile duct. Compared with a 19G needle, the 22G needle offers more flexible manipulation and superior ability to achieve bile duct puncture. However, evidence regarding EUS‐HGS using a 22G needle remains limited. The present study evaluated the feasibility and safety of EUS‐HGS using a novel 0.018‐inch guidewire and 22G needle for patients with insufficient intrahepatic bile duct dilation. If the bile duct diameter was <1.5 mm, a 22G needle was used, and the diameter was ≥1.5 mm; puncture with a 19G needle was first attempted, with the 22G needle being inserted if initial bile duct puncture failed. EUS‐HGS using the 22G needle was attempted in a total of 10 patients, including one patient with failed insertion of a 19G needle. Median diameter of the puncture site was 1.2 mm (range 0.5–2.5 mm). Bile duct puncture using the 22G needle was successful in all patients. Insertion of the novel 0.018‐inch guidewire was also successful in all patients. However, since tract dilation using an ultra‐tapered mechanical dilator failed in two patients, tract dilation was performed using a balloon dilator. Finally, stent deployment was successfully performed in all patients. EUS‐HGS using a 22G needle with a novel 0.018‐inch guidewire appears safe and feasible. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Endoscopic ultrasonography‐guided hepaticogastrostomy using a novel laser‐cut type partially covered self‐expandable metal stent (with video).
- Author
-
Ogura, Takeshi, Kitano, Masayuki, Okuda, Atsushi, Itonaga, Masahiro, Ueno, Saori, Yamashita, Yasunobu, Nishioka, Nobu, Ashida, Reiko, Miyano, Akira, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,ENDOSCOPIC retrograde cholangiopancreatography ,BILIARY tract - Abstract
Endoscopic ultrasonography (EUS)‐guided hepaticogastrostomy (HGS) is of clinical benefit in patients with failed endoscopic retrograde cholangiopancreatography (ERCP). However, some endoscopists are concerned about the potential risk of adverse events. Bile peritonitis due to bile leakage through the fistula is one of the possible adverse events following EUS‐HGS. Recently, a novel laser‐cut type partially covered self‐expandable metal stent (PCSEMS), which is a dedicated stent for EUS‐HGS, has become available. This stent has an uncovered part, despite it being a laser‐cut type stent, along with a flared end. In addition, it uses a 7‐Fr stent delivery. Therefore, tract dilation might not be needed to deploy the stent, which might reduce the incidence of stent migration. In this study, the safety of EUS‐HGS using this novel laser‐cut type PCSEMS was evaluated by assessing technical success, which was defined as successful stent deployment, and clinical success, which was defined as reduction in serum total bilirubin levels by 50% and resolution of symptoms related to biliary tract obstruction within 2 weeks. Five patients with unresectable malignant biliary obstruction underwent EUS‐HGS using the novel stent. Stent deployment was successfully performed without tract dilation in four patients, although tract dilation using a balloon catheter was needed in one patient. Clinical success was obtained in all patients, and adverse events including abdominal pain and bile peritonitis were not observed in any of the patients. EUS‐HGS without tract dilation can be safely performed using a novel laser‐cut type PCSEMS. A prospective comparative study evaluating this stent versus conventional stents is needed to corroborate our results. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. EUS‐guided hepaticogastrostomy for hepaticojejunostomy stricture using a 22G needle and a mechanical dilator (with video).
- Author
-
Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, and Higuchi, Kazuhide
- Abstract
EUS‐guided biliary drainage (EUS‐BD) has been indicated for benign biliary strictures. However, the intrahepatic bile duct is sometimes much narrower in benign biliary strictures. In this situation, puncture of the intrahepatic bile duct using a 19‐G needle is sometimes challenging. Several reports have described attempts at EUS‐BD using a 22‐G needle, but fistula dilation with a 22‐G needle is challenging because the 0.018‐inch guidewire is not stiff enough to perform dilatation. Recently, a thin mechanical dilator has become available. After its insertion into the biliary tract, the 0.018‐inch guidewire can be replaced with a 0.025‐inch guidewire. We herein describe the technical procedure of EUS‐guided hepaticogastrostomy using a 22‐G needle with a thin mechanical dilator. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Effect of echoendoscope angle on success of guidewire manipulation during endoscopic ultrasound-guided hepaticogastrostomy.
- Author
-
Ogura, Takeshi, Nishioka, Nobu, Ueno, Saori, Yamada, Tadahiro, Yamada, Masanori, Imoto, Akira, Hakoda, Akitoshi, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,INTRAHEPATIC bile ducts ,RECEIVER operating characteristic curves ,NEEDLE biopsy ,LOGISTIC regression analysis ,ULTRASONIC imaging ,OPERATIVE surgery ,RETROSPECTIVE studies ,CATHETERIZATION ,BILIARY tract surgery - Abstract
Background: With endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS), guidewire manipulation might be a critically limiting step for nonexperts. However, the causes of difficult guidewire manipulation remain unclear. The aim of this study was to evaluate factors associated with successful guidewire manipulation.Methods: This retrospective cohort study included consecutive patients who underwent EUS-HGS between October 2018 and October 2019. We measured scope angle between the long and needle axes of the echoendoscope using still fluoroscopic imaging immediately after puncturing the intrahepatic bile duct. Factors associated with successful guidewire insertion were assessed by multivariable analysis using logistic regression.Result: The influence of the angle between the fine-needle aspiration (FNA) needle and echoendoscope on failed guidewire insertion was assessed using receiver operating characteristic (ROC) curves. Area under the ROC curve was 0.86 (95 % confidence interval [CI] 0.00 - 0.76), and an angle of 135° offered 88.0 % sensitivity and 82.9 % specificity for predicting successful guidewire insertion. According to multivariable analysis, only angle between the FNA needle and echoendoscope > 135° was independently associated with successful guidewire insertion (odd ratio 0.03, 95 %CI 0.01 - 0.14; P < 0.05), whereas sex, puncture site, and diameter of puncture site were not significant factors. After multivariable analysis, all variables were adjusted using age ≥ 70 or < 70 years, yielding the same results.Conclusion: The angle between the FNA needle and echoendoscope might be associated with successful guidewire manipulation during EUS-HGS. Adjusting this angle to 135° before puncturing the intrahepatic bile duct might be helpful in achieving successful guidewire manipulation during EUS-HGS. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
14. Recanalization of a distorted duodenal metal stent using a fine-gauge electrocautery dilator.
- Author
-
Okuda, Atsushi, Ogura, Takeshi, Yamada, Masanori, Ueno, Saori, and Higuchi, Kazuhide
- Subjects
ELECTROCOAGULATION (Medicine) ,ENDOSCOPIC ultrasonography ,GASTRIC outlet obstruction ,PANCREATIC cancer ,SURGICAL stents ,METALS ,ENDOSCOPIC surgery ,DRUG-eluting stents ,CHOLESTASIS - Abstract
However, if a transpapillary bile duct stent has previously been deployed, duodenal stents can become distorted by the bile duct stent. We herein describe technical tips for recanalization of a distorted duodenal metal stent using a novel fine-gauge electrocautery dilator (Medico's Hirata Inc., Osaka Japan) [5]. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
15. Triple Covered Metal Stent Deployment Using Side-by-Side Technique for Hemobilia due to Hepatocellular Carcinoma (with Video).
- Author
-
Ogura, Takeshi, Yamada, Tadahiro, Yamada, Masanori, Ueno, Saori, and Higuchi, Kazuhide
- Subjects
HEPATOCELLULAR carcinoma ,BILE ducts ,BILIARY tract ,TECHNICAL reports ,METALS ,CHOLANGITIS - Abstract
A hepatocellular carcinoma (HCC) rarely expands into the biliary tract. In this situation, because of its hypervascular nature, cholangitis or hemobilia may sometimes occur. Surgery is one of the options in this situation. However, patients with HCC and bile duct invasion are sometimes in a poor general condition, as in the case presented in this report. For such patients, surgical treatment may need to be invasive. Thus, here we report technical tips for triple covered metal stent deployment using side-by-side technique for hemobilia due to HCC. After guidewire deployments at the left, anterior, and posterior bile ducts, 6-mm covered self-expandable metal stents were placed at each bile duct. This may be useful for high-grade hepatic hilar obstruction due to HCC because drainage and hemostasis effects are obtained. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Single‐session multiple stent deployment using moving cell stent without dilating initial stent mesh to treat malignant hilar biliary obstruction (with videos).
- Author
-
Ogura, Takeshi, Takenaka, Mamoru, Shiomi, Hideyuki, Nishioka, Nobu, Ueno, Saori, Miyano, Akira, Kamiyama, Rieko, and Higuchi, Kazuhide
- Abstract
Background: Malignant hilar biliary obstruction (MHBO) can be treated with bilateral self‐expandable metal stents (SEMS) deployed using side‐by‐side (SBS) or stent‐in‐stent (SIS) techniques. Moving cell stents (MCS) are a novel type of SEMS. The present study evaluated the technical feasibility of treating MHBO using bilateral novel uncovered SEMS to insert an SIS technique without dilating the mesh of a first stent within a single session. Method: We retrospectively assessed patients who were complicated with obstructive jaundice due to MHBO between August and December 2018. Technical success was defined as the deployment of a bilateral MCS into two or more biliary tracts using SIS technique without a dilation device. Results: The present study analyzed data from 23 consecutive patients who were complicated with MHBO. Bilateral SIS technique with MCS was deployed in 22 (95.6%) of the 23 patients without dilating the mesh of the first stent. Multiple guidewire insertion failed in one patient with Bismuth‐type IV. The median procedural duration was 33.6 min. Time to recurrent biliary obstruction was 230 days. Severe adverse events were not seen in any patients. Conclusion: In conclusion, uncovered moving cell SEMS might facilitate bilateral stent deployment using SIS technique. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. A case of adenocarcinoma developed in the small intestine with chronic strongyloidiasis.
- Author
-
Ishikawa, Satoshi, Maeda, Tamaki, Hattori, Kimiaki, Watanabe, Takahiro, Kuramoto, Takanori, Ueno, Saori, Ueno, Goro, Yamada, Tadahiro, Kanazawa, Akifumi, Sakaguchi, Masahiro, and Tsukamoto, Yoshitane
- Abstract
We experienced a case of intestinal strongyloidiasis complicated by jejunal carcinoma. A Japanese male in his 50s, who has a 7-year medical history of duodenal ulcers, complained of loss of appetite, nausea, vomiting and diarrhea. Computed tomography and gastroduodenal endoscopic examination revealed a stenosis of the duodenum. To remove the stenosis, gastric bypass surgery was performed. The pathological diagnosis of the resected jejunum was strongyloidiasis and well-differentiated adenocarcinoma with subserosal invasion and vascular infiltration. After administration of Ivermectin, Strongyloides stercoralis was not found in any biopsies or in the specimens of the intestine, which were resected due to cancer recurrence 2 years later. There are three possibilities for the reason of coexistence of S. stercoralis and adenocarcinoma: S. stercoralis caused the adenocarcinoma, S. stercoralis moved to the carcinoma, or just coincidence. Although it is difficult to prove a causal relationship between S. stercoralis and adenocarcinoma, this is the first report of adenocarcinoma developed in the jejunum with chronic strongyloidiasis. The number of nematode infections, including strongyloidiasis, is decreasing in Japan, although not worldwide. Therefore, it should be considered in patients with prolonged intestinal ulcers. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
18. Across-the-papilla side-by-side deployment of three braided stents for malignant hilar biliary obstruction.
- Author
-
Ueno, Saori, Ogura, Takeshi, Kawai, Jyunichi, Yamamura, Masahiro, and Higuchi, Kazuhide
- Subjects
BILE duct tumors ,CHOLESTASIS ,CHOLANGIOCARCINOMA ,SURGICAL stents ,RETROSPECTIVE studies ,TREATMENT effectiveness ,BILE ducts ,PALLIATIVE treatment ,DISEASE complications - Abstract
Because of the fine gauge of the stent delivery system, second and third stent insertions beside the first stent deployment may be feasible. Finally, the stent delivery system was successfully inserted into the posterior bile duct beside the two stents and a third 6-mm braided stent was deployed in the anterior bile duct across the papilla (Fig. 17115635-7d0930ee.mp4 The 6-mm braided stent may facilitate SBS stent deployment, although its utility for across-the-papilla SBS stenting needs to be evaluated in prospective clinical trials. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
19. Antegrade metal stent deployment under endoscopic ultrasound guidance using a novel uncovered metal stent with a fine-gauge stent delivery system.
- Author
-
Miyano, Akira, Ogura, Takeshi, Ueno, Saori, Nishioka, Nobu, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,SURGICAL stents - Abstract
1 Cell width of the novel uncovered self-expandable metal stent (YABUSAME; Kaneka, Tokyo, Japan) is small compared with the conventional type, particularly in the part where bending force is applied. a YABUSAME stent. b Conventional uncovered self-expandable metal stent. Additionally, to prevent stent misplacement or dislocation, a laser-cut-type uncovered self-expandable metal stent (UCSEMS) may be favorable compared with a fully covered metal stent (FCSEMS), although stent patency is shorter. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
20. Moving scope technique for guidewire insertion during endoscopic ultrasound‐guided hepaticogastrostomy.
- Author
-
Ueno, Saori, Ogura, Takeshi, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,VIDEOS - Abstract
Watch a video of this article. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. One‐step deployment for EUS‐guided gallbladder drainage using a novel fully covered metal stent (with video).
- Author
-
Ogura, Takeshi, Ueno, Saori, Okuda, Atsushi, Nishioka, Nobu, and Higuchi, Kazuhide
- Published
- 2021
- Full Text
- View/download PDF
22. Reverse knuckle guidewire insertion technique for endoscopic ultrasound-guided hepaticogastrostomy using a novel 0.025-inch guidewire.
- Author
-
Ogura, Takeshi, Yamada, Masanori, Yamada, Tadahiro, Ueno, Saori, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,CONTRAST media ,INTRAHEPATIC bile ducts ,ENDOSCOPIC retrograde cholangiopancreatography ,BILIARY tract ,BILE ducts ,PANCREATIC duct ,BILIARY tract surgery ,CATHETERIZATION ,OPERATIVE surgery ,ULTRASONIC imaging - Published
- 2020
- Full Text
- View/download PDF
23. Endoscopic nasal biliary drainage-guided approach after endoscopic ultrasound-guided hepaticojejunostomy: safe stent exchange technique.
- Author
-
Ogura, Takeshi, Ueno, Saori, Tanaka, Yasukichi, Hara, Azusa, and Higuchi, Kazuhide
- Subjects
ENDOSCOPIC ultrasonography ,CONTRAST media ,ENDOSCOPIC retrograde cholangiopancreatography ,CHOLESTASIS ,SURGICAL stents ,ULTRASONIC imaging ,MEDICAL drainage - Published
- 2020
- Full Text
- View/download PDF
24. Impacted intrahepatic bile duct stone removal using transluminal intervention technique.
- Author
-
Ogura, Takeshi, Ueno, Saori, and Higuchi, Kazuhide
- Subjects
INTRAHEPATIC bile ducts ,ENDOSCOPIC retrograde cholangiopancreatography ,SURGICAL & topographical anatomy ,CHOLANGITIS ,ENTEROSCOPY - Published
- 2020
- Full Text
- View/download PDF
25. Transluminal stone removal from right intrahepatic bile duct using novel basket catheter.
- Author
-
Ogura, Takeshi, Nishioka, Nobu, Ueno, Saori, Yamada, Tadahiro, and Higuchi, Kazuhide
- Subjects
INTRAHEPATIC bile ducts ,CATHETERS ,CALCULI ,BASKETS - Abstract
B Video 1 b Small bile duct stones persisting in the periphery of the intrahepatic bile duct were removed using the novel basket catheter. 2 Cholangiographic images. a Bile duct stones and stenosis were evident in the right intrahepatic bile duct. b The bile duct stenosis was dilated using a balloon catheter. c Endoscopic hydraulic lithotripsy. d Removal of right intrahepatic bile duct stones using the novel basket catheter. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
26. Success of stent-in-stent deployment after intraductal radiofrequency ablation for hepatic hilar obstruction.
- Author
-
Ogura, Takeshi, Ueno, Saori, Nishioka, Nobu, Yamada, Masanori, and Higuchi, Kazuhide
- Subjects
CATHETER ablation ,ENDOSCOPIC ultrasonography ,BILE ducts - Abstract
A cholangioscope inserted before intraductal RFA to prevent bile duct perforation revealed a tumor in the bile duct (Fig. 3 Cholangiography views. a The dilated bile duct after radiofrequency ablation. b Deployment of multiple uncovered self-expandable metal stents was easily achieved using the stent-in-stent technique. 2018, 15, 722 - 727 4 Chahal P., Baron T. H. Expandable metal stents for endoscopic bilateral stent-within-stent placement for malignant hilar biliary obstruction. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.